Risk factors for postoperative hemorrhage after vitrectomy for diabetic retinopathy

Ophthalmic Epidemiology

Volumn 12, Issue 5, 2005, Pages 335-341

  Soto Pedre, Enrique ^a   Hernaez Ortega, Maria Concepcion ^a,b   Vazquez, Jose Antonio ^b  

^a EUROPEAN INNOVATIVE BIOMEDICINE INSTITUTE   (Spain)

^b HOSPITAL DE CRUCES   (Spain)

Author keywords

Antihypertensive agents; Diabetic retinopathy; Postoperative complications; Vitrectomy; Vitreous hemorrhage

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; APHAKIA; CILIARY DISK; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC RETINOPATHY; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; LEG AMPUTATION; MALE; NEOVASCULARIZATION (PATHOLOGY); POSTOPERATIVE HEMORRHAGE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; RISK FACTOR; RISK REDUCTION; VITRECTOMY;

AGED; ANTIHYPERTENSIVE AGENTS; CASE-CONTROL STUDIES; DIABETIC RETINOPATHY; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; RISK FACTORS; VITRECTOMY; VITREOUS HEMORRHAGE;

EID: 28244463890     PISSN: 09286586     EISSN: 17445086     Source Type: Journal    
DOI: 10.1080/09286580500227068     Document Type: Review

References (30)

1. Mieler WF, Wolf MD. Management of postvitrectomy diabetic vitreous hemorrhage. In: Lewis H, Ryan SJ, eds. Medical and surgical retina. Advances, controversies and management. St. Louis: Mosby, 1994;330-340.
2. Wacholder S, McLaughlin JK, Silverman DT, Mandel JS. Selection of controls in Case-Control studies. I. Principles. Am J Epidemiol. 1992;135(9):1019-1028.
3. StataCorp. Stata reference manual, release 5.0. College Station, TX: Stata Corporation, 1997.
4. Lemeshow S, Hosmer W. A review of goodness of fit statistics for use in the development of logistic regression models. Am J Epidemiol. 1982;115:92-106.
5. Thompson JT, De Bustros S, Michels RG, Rice TA, Glaser BM. Results of vitrectomy for proliferative diabetic retinopathy. Ophthalmology. 1986;93:1571-1574.
6. Diabetic Retinopathy Vitrectomy Study Research Group. Early vitrectomy for severe vitreous hemorrhage in diabetic retinopathy: four-year results of a randomized trial. Diabetic Retinopathy Vitrectomy Study report 5. Arch Ophthalmol. 1990;108:958-964.
7. Smiddy WE, Feuer W, Irvine D, Flynn HW, Blankenship GW. Vitrectomy for complications of proliferative diabetic retinopathy. Ophthalmology. 1995;102:1688-1695.
8. Blankenship GW, Machemer R. Long-term diabetic vitrectomy results. Report of 10 year follow-up. Ophthalmology. 1985;92:503-506.
9. Aaberg TM, Abrams GW. Changing indications and techniques for vitrectomy in management of complications of diabetic retinopathy. Ophthalmology. 1987;94:775-779.
10. Ho T, Smiddy WE, Flynn HW. Vitrectomy in the management of diabetic eye disease. Surv Ophthalmol. 1992;37:190-202.
11. Spraul CW, Grossniklaus HE. Vitreous hemorrhage. Surv Ophthalmol. 1997;42:3-39.
12. Yang CM. Surgical treatment for diabetic retinopathy: 5-year experience. J Formosan Med Assoc. 1998;97:477-484.
13. Robins JM, Greenland S. The role of model selection in causal inference from nonexperimental data. Am J Epidemiol. 1986;123(3):392-402.
14. Schachat AP, Oyakawa RT, Michels RG, Rice TA. Complications of vitreous surgery for diabetic retinopathy. II. Postoperative complications. Ophthalmology. 1983;90:522-530.
15. Novak MA, Rice TA, Michels RG, Auer C. Vitreous hemorrhage after vitrectomy for diabetic retinopathy. Ophthalmology. 1984;91:1485-1489.
16. Blankenship GW. Management of vitreous cavity hemorrhage following pars plana vitrectomy for diabetic retinopathy. Ophthalmology. 1986;93:39-44.
17. Liggett PE, Lean JS, Barlow WE, Ryan SJ. Intraoperative argon endophotocoagulation for recurrent vitreous hemorrhage after vitrectomy for diabetic retinopathy. Am J Ophthalmol. 1987;103:146-149.
18. Thompson JT, Bustros S, Michels RG, Rice TA. Results and prognostic factors in vitrectomy for diabetic vitreous hemorrhage. Arch Ophthalmol. 1987;105:191-195.
19. Tolentino FI, Cajita VN, Gancayco T, Skates S. Vitreous hemorrhage after closed vitrectomy for proliferative diabetic retinopathy. Ophthalmology. 1989;96:1495-1500.
20. Sima P, Zoran T. Long-term results of vitreous surgery for proliferative diabetic retinopathy. Doc Ophthalmol. 1994;87:223-232.
21. Fernández de Mendiola J, Iza A, Lasa I, et al. Evaluación de la población diabética tipo II atendida en un equipo de atención primaria. Atención Primaria. 1996;17:432-438.
22. Blankenship GW. The lens influence on diabetic vitrectomy results. Arch Ophthalmol. 1980;98:2196-2198.
23. Rice TA, Michels RG, Maguire MG, Rice EF. The effect of lensectomy on the incidence of iris neovascularization and neovascular glaucoma after vitrectomy for diabetic retinopathy. Am J Ophthalmol. 1983;95:1-11.
24. Thompson JT, Auer CL, De Bustros S, et al. Prognostic indicators of success and failure in vitrectomy for diabetic retinopathy. Ophthalmology. 1986;93:290-295.
25. De Bustros S, Thompson JT, Michels RG, Rice TA. Vitrectomy for progressive proliferative diabetic retinopathy. Arch Ophthalmol. 1987;10:196-199.
26. Hesse L, Bodanowitz S, Hühnermann M, Kroll P. Prediction of visual acuity after early vitrectomy in diabetics. German J Ophthalmol. 1996;5:257-261.
27. Helbig H, Kellner U, Bornfeld N, Foerster MH. Vitrectomy in diabetic retinopathy: outcome, risk factors, complications. Klin Monatsbl Augenheilkd. 1998;212:339-342.
28. Goodart R, Blankenship G. Panretinal photocoagulation influence on vitrectomy results for complications of diabetic retinopathy. Ophthalmology. 1980;87:183-188.
29. Rothman KJ. Modern epidemiology. Boston: Little, Brown & Company, 1986.
30. Adan A, Corcostegui B, Garcia J, Mateo C, Nieto I. Hemorragia vítrea densa posterior a vitrectomia en la retinopatía diabética: análisis de 20 pacientes. Arch Soc Esp Oftalmol. 1992;62:369-372.